• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Asthma Research Update: 7 Studies At-a-Glance for Primary Care

Article

Recent studies have reported the latest developments in asthma research. Scroll through these slides to find concise summaries of key points for clinical practice.

Recent studies have reported the latest developments in asthma research. Scroll through the slides below to find concise summaries of key points for clinical practice.

Related Videos
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Related Content
FDA Approves Benralizumab as Add-On Maintenance Therapy for Children with Severe Asthma: Daily Dose / image credit: ©New Africa/AdobeStock

FDA Approves Benralizumab as Add-On Maintenance Therapy for Children with Severe Asthma: Daily Dose

April 19th 2024
Article

Your daily dose of the clinical news you may have missed.

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

May 20th 2022
Podcast

In our latest podcast episode, Njira Lugogo, MD, discusses NAVIGATOR data she presented at ATS 2022 that showed clinical responses to treatment with tezepelumab.

FDA Approves Benralizumab as Add-On Maintenance Therapy for Children Aged 6-11 Years with Severe Asthma / Image credit: ©Argus/AdobeStock

FDA Approves Benralizumab as Add-On Maintenance Therapy for Children Aged 6-11 Years with Severe Asthma

April 11th 2024
Article

The additional indication for benralizumab was supported by data from the phase 3 TATE trial.

Site Logo

Eternal Springs

January 13th 2010
Podcast

Doctors, especially primary care doctors, love stories. We love hearing them from patients and telling them to one another. “Anecdotal learning” it’s called by some (somewhat derisively because it’s not science).

Dupilumab Plus Medium-Dose Inhaled Corticosteroid Improves Lung Function, Asthma Control: Daily Dose / image credit: ©New Africa/AdobeStock

Dupilumab Plus Medium-Dose Inhaled Corticosteroid Improves Lung Function, Asthma Control: Daily Dose

February 29th 2024
Article

Your daily dose of the clinical news you may have missed.

Ethnic Minorities Found More Likely to Require Change in Biologic Therapy for Severe Asthma / Image credit: ©molekuule.be/AdobeStock

Ethnic Minorities Found More Likely to Require Change in Biologic Therapy for Severe Asthma

February 23rd 2024
Article

New data presented at AAAAI 2024 sheds light on real-world patterns of biologic use in a diverse patient population with severe asthma.

© 2024 MJH Life Sciences

All rights reserved.